0001104659-21-000919.txt : 20210105
0001104659-21-000919.hdr.sgml : 20210105
20210105160902
ACCESSION NUMBER: 0001104659-21-000919
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201231
FILED AS OF DATE: 20210105
DATE AS OF CHANGE: 20210105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bakshi Akash
CENTRAL INDEX KEY: 0001836243
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37809
FILM NUMBER: 21505491
MAIL ADDRESS:
STREET 1: 602 BAINBRIDGE STREET
CITY: FOSTER CITY
STATE: CA
ZIP: 94404
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeuroBo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001638287
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472389984
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 BERKELEY ST.
STREET 2: FL 19
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: (857) 702-9600
MAIL ADDRESS:
STREET 1: 200 BERKELEY ST.
STREET 2: FL 19
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: Gemphire Therapeutics Inc.
DATE OF NAME CHANGE: 20150331
4
1
a4.xml
4
X0306
4
2020-12-31
0
0001638287
NeuroBo Pharmaceuticals, Inc.
NRBO
0001836243
Bakshi Akash
C/O NEUROBO PHARMACEUTICALS, INC.,
200 BERKELEY STREET, OFFICE 19TH FLOOR
BOSTON
MA
02116
1
1
0
0
SVP and COO
Common Stock
2020-12-31
4
A
0
29013
A
29013
D
Common Stock
2020-12-31
4
A
0
855059
A
884072
I
See Footnote
Received in exchange for shares of ANA Therapeutics, Inc. ("ANA") common stock in connection with the acquisition of ANA by the Company.
The reportable securities are owned directly by YourChoice Holdings, LLC ("YourChoice"). Mr. Bakshi is the CEO and a director of YourChoice. Mr. Bakshi disclaims beneficial ownership of the securities reported herein for the purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of his pecuniary interest therein, if any.
/s/ Akash Bakshi
2021-01-05